Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

ANATARA LIFESCIENCES LTD

INVESTOR PRESENTATION - ANATARA LIFESCIENCES LTD

ASX:ANR

ANATARA LIFESCIENCES LTD

Health Care

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Read more

Market Cap

9.99m

Price at Close

$0.2

4w avg. Volume

15.38k

4w avg. Turnover

$3.13k

Announcements
announcementt+2 movementdate
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • -

    18 Oct 2020

-

18 Oct 2020
  • Non-Executive Director Retirement

    Company Administration

  • -

    18 Oct 2020

-

18 Oct 2020
  • Appendix 2A

    Issued Capital

  • -4.35%

    15 Sep 2020

-4.35%

15 Sep 2020
  • Investor Presentation

    Periodic Reports

  • -4.76%

    07 Sep 2020

-4.76%

07 Sep 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    02 Sep 2020

0.00%

02 Sep 2020
  • Appendix 4E & Financial Report 30 June 2020

    Periodic Reports · Market sensitive

  • +6.82%

    24 Aug 2020

+6.82%

24 Aug 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    11 Aug 2020

0.00%

11 Aug 2020
  • Anatara Animal Health Update

    Progress Report

  • +3.85%

    09 Aug 2020

+3.85%

09 Aug 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • -3.45%

    29 Jul 2020

-3.45%

29 Jul 2020
  • Cancelled Options

    Issued Capital

  • +3.85%

    02 Jul 2020

+3.85%

02 Jul 2020
Market Data

Current Price

$0.2

52WK HIGH

$0.45

52WK LOW

$0.13

1YR RETURN

-4.76%

1YR RETURN VS. SECTOR

-32.46%

90 DAY RETURN

+25.00%

ASX RANK

1,700

/2,010

SECTOR RANK

42

/47

SHARES OUTSTANDING

49.93m
ASX:ANR

ANATARA LIFESCIENCES LTD

Health Care

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Read more

Market Cap

9.99m

Price at Close

$0.2

4w avg. Volume

15.38k

4w avg. Turnover

$3.13k

Bidding closed

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.